using targeted therapies to optimize transplant outcomes in aml
Published 1 year ago • 72 plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
2:42
the use of targeted therapy to prevent relapse post-transplant
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
58:13
optimising transplant outcome in adults allografted for aml
-
1:36
targeted therapy for aml
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
2:15
vipor: a multi-targeted therapy for the treatment of r/r dlbcl
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all
-
2:43
t-cell engaging treatment in aml
-
14:43
current research into post-allosct maintenance therapy in aml
-
1:37
transplantation: a holistic approach
-
2:23
the use of solid organ transplant in al amyloidosis
-
1:13
efficacy of transplantation in hl
-
5:18
upfront treatment in transplant candidates
-
2:39
a look into the future of multiple myeloma treatment: t-cell redirecting therapies vs autohsct